The Global sales of Nutraceuticals Excipients market was USD 2,050.1 million in 2019. Historical CAGR growth was recorded at 5.1% from 2019 to 2034 with revenues expected to reach USD 2,663.4 million in 2024. Looking ahead, the global industry is forecast to expand at a CAGR of 6.4% over the next ten years and reach a market size of USD 4.952.8 million by the end of 2034.
Consumer emphasis on health and wellness is driving the dynamic evolution of the global nutraceutical excipients industry. Nutraceutical products are formulated using excipients, which are inactive substances used to carry active ingredients. Companies in the sector are constantly innovating by developing advanced excipients that improve the bioavailability, stability, and taste of their nutraceuticals.
The market is shaped by trends such as rise of clean-label products, personalized nutrition, and advances in liquid excipients. Additionally, increased awareness about health-related issues is contributing to industry growth as well as while countries like Japan that have an increasing aging population along with India that has a growing number of middle-class customers.
The production processes and sourcing of raw materials are being upgraded as a result of sustainability and eco-friendly practices. On a more general note, innovations in technology combined with changing customer preferences will see this industry grow at high rates.
| Attributes | Description |
|---|---|
| Estimated Global Industry Size (2024E) | USD 2,663.4 Million |
| Projected Global Value (2034F) | USD 4,952.8 Million |
| Value-based CAGR (2024 to 2034) | 6.4% |
The table below presents a comparative assessment of the variation in CAGR over six months for the base year (2023) and current year (2024) for the Global IQF Fruits & Vegetables industry.
This analysis reveals crucial shifts in industry performance and indicates revenue realization patterns, thus providing stakeholders with a better vision of the ecosystem growth trajectory over the year. The first half of the year, or H1, spans from January to June. The second half, H2, includes the months from July to December.
| Particular | Value CAGR |
|---|---|
| H1 | 5.6% (2023 to 2033) |
| H2 | 5.9% (2023 to 2033) |
| H1 | 6.7% (2024 to 2034) |
| H2 | 6.3% (2024 to 2034) |
The above table presents the expected CAGR for the global IQF Fruits & Vegetables industry over several semi-annual periods spanning from 2024 to 2034. In the first half (H1) of the decade from 2023 to 2033, the business is predicted to surge at a CAGR of 5.6%, followed by a slightly higher growth rate of 5.9% in the second half (H2) of the same decade.
Moving into the subsequent period, from H1 2024 to H2 2034, the CAGR is projected to increase slightly to 6.7% in the first half and remain relatively moderate at 6.3% in the second half.
Consumer preference leading to rise of clean-label excipients
There is a rising consumer demand for clean-label products that do not contain artificial additives or preservatives. For this reason, natural or organic excipients that meet these needs are increasingly being developed. In order to be seen as transparent about environmental matters, many manufacturers now use natural sources for their starting materials when making excipients so that they can be considered sustainable.
This change meets customer requirements while also adhering to regulatory standards requiring healthier and less synthetic ingredients in functional food or food supplements.
Increased production of Liquid excipients due to their enhanced solubility
Liquid excipients have undergone significant advancements within the nutraceutical excipient industries over time, especially through liquid excipient technology.
Such enhancements focus on improving the solubility and bioavailability of various actives thus making them more efficient when administered to patients and hence, reducing toxicity levels associated with poor drug absorption. Liquid forms are particularly preferred due to their quick absorptive ability and easy ingestion into the system for specific formulation purposes.
Growing demand for personalized nutrition and excipients
The demand for personalized nutrition has made consumers look for individualized dietary solutions that are based on their unique health problems and genetic makeup. This has led to the creation of more specialized excipients which can be used to tailor nutraceutical products.
Companies have focused on developing excipients that can fit all types of formulations, enabling personalization of nutrition products; which tends to be highly effective and attract many customers. Consequently, this method will transform these industries giving them a human touch.
Global sales increased at a CAGR of 5.1% from 2019 to 2023. For the next ten years (2024 to 2034), projections are that expenditure on the industry will rise at 6.4% forecast CAGR.
In the recent past, the global industry has changed significantly since its inception several decades ago. Initially, it started with modest growth due to consumer knowledge about health and wellness issues.
Previously, this sector encountered some obstacles including regulatory issues relating to product quality concerns among other safety measures which needed to be met at high costs. However, it also created an opportunity for innovation leading to the formulation of excipients that boost bioavailability levels while enhancing stability features related to nutritive elements or components in medicinal foods or food additives.
The future of nutraceutical excipients industry looks promising. Personalization of nutrition and integration of advanced technologies such as nanotechnology and biotechnology is likely to increase innovation.
Moreover, new excipients are being developed under the influence of the trend toward clean-label products and natural ingredients. Also, rising disposable incomes and health consciousness among emerging markets' middle class are indicators of increased prospects for this industry.
The nutraceutical excipients industry is a well-structured market mix that has a combination of big, moderate, and small players. The giants in the industry are the tier-1 players with global presence, advanced R&D facilities, and broad product range. An example can be BASF or DuPont among others. These companies control the market by about 50-60%. They form benchmarks for the entire industry as well as spur innovation.
Tier-2 players represent mid-sized firms with local focus and a narrow product line. They usually work with Tier-1 firms or serve niche markets. These businesses account for around 25-35% of overall output per annum. They fulfill specific regional demands and provide individual solutions for them.
To this end; smaller companies or start-ups constitute Tier 3 players who have limited coverage in terms of market and products serving some localized characteristics or segments within the field such as; such examples would include smaller local businesses or new emerging ones respectively. Together, they possess up to 10-20% of total value share. In time-sensitive ways, they take advantage of being nimble and offer new drugs in their portfolios.
Therefore, it can be seen that the nutraceutical excipients industry is divided into three tiers with tier one companies dominating followed by tier two and then three respectively throughout the world. Each level contributes to its development and diversity in the industry's ecosystem on which it depends. This hierarchical structure allows for an even competition between different levels leading to innovations.
The following table shows the estimated growth rates of the top five markets. USA and China are set to exhibit high consumption, recording CAGRs of 7.2% and 8.5%, respectively, through 2034.
| Countries | CAGR 2024 to 2034 |
|---|---|
| USA | 5.8% |
| Germany | 5.3% |
| Japan | 6.5% |
| China | 7.2% |
| India | 8.0% |
In the USA, consumers' great awareness about nutraceuticals highly boosts sales in the sector. USA customers are now focusing more and more on health, which has made them prefer supplements to improve their general well-being. This is driven by easy access to information about nutraceutical advantages that are supported by healthcare practitioners and the media alike.
Consequently, organizations have started investing in new enhancers for making good quality, effective products that meet the rising need. The state of consumer knowledge concerning health promotion and maintenance plays a crucial role in driving this market forward within American borders.
The industry for Nutraceutical Excipients in the United States is projected to exhibit a CAGR of 5.8% during the assessment period and revenue from the sales of Nutraceutical Excipients in the country is expected to reach USD 1,505.7 million with a market share of 30.4%.
Japan's rapidly aging population is an important contributing factor to the growth of the nutraceutical excipients landscape. This happens when a country undergoes a demographic change with a majority of its people turning old, therefore leading to an increase in demand for supplements that support conditions related to age.
Nutraceuticals that improve joint health, brain functions, and overall body strength are much loved by many people. This results in the need for more advanced excipients which would enhance the efficiency and stability of these products. In turn, firms are concentrating on creating specific formulations to address unique health issues facing Japan’s aged population.
These trends are leading to a projected value of USD 658.7 million by 2034 with Nutraceutical Excipients demand calculated to rise at a value CAGR of 6.5% during the forecast period (2024 to 2034) with a value share of 13.3%.
The incidence of lifestyle diseases among middle-class people in India has been on the rise; thereby expanding the market for nutraceutical excipients. With many individuals falling sick due to diabetes, high blood pressure, and obesity among other illnesses; there has been a rise in demand for dietary supplements meant for disease management as well as prevention.
Soaring healthy eating consciousness among middle-class citizens as well as increased disposable income boosts consumption of nutraceuticals. In light of this movement, manufacturers encourage production of novel excipients that would enhance drug bioavailability and efficacy aimed at addressing their specific health requirements and growing new markets.
These factors are responsible for the robust projected forecast CAGR of 8.0% from 2024 to 2034, with the country achieving a global value share of 7.8% in 2034 with a value of USD 386.3 million.
| Segment | Fillers & Diluents (Product Type) |
|---|---|
| Value Share (2024) | 29.2% |
In the Global Nutraceutical Excipients Industry, fillers and diluents ensure that nutraceutical products remain consistent and stable all through their shelf life. They help achieve the desired bulkiness and uniformity hence tablets, capsules, and powders with accurate doses can easily be manufactured. Moreover, they enhance texture as well as flowability hence customers receive dependable and efficient supplements.
For this reason, companies include fillers such as diluents in their formulas so as to meet quality standards while enhancing consumer experience. With a dominating share of 29.2%, this segment has an estimated value of USD 1,446.2 million in 2034 and is projected to grow at a forecast CAGR of 7.3%.
| Segment | Vitamins (End Use) |
|---|---|
| Value Share (2024) | 36.4% |
There is increasing consumer awareness towards dietary supplements, especially vitamins. These vitamin supplements comprise of nutraceutical excipients that play an essential role in improving the bioavailability and stability other than effectiveness.
Because of this, manufacturers are concentrating on the utilization of more developed excipients in order to meet these consumer needs. In addition to that, it is evident that nutraceutical excipients have been increasingly used in vitamin products due to evolving demand for essential micronutrients which are required by specific body systems.
This growth has propelled its value to USD 1,802.8 million in 2034 with a market share of 36.4% and further projections suggest its growth at a CAGR of 6.2%.
The Global Nutraceutical Excipients Industry has witnessed a surge in growth as a result of strategic mergers and acquisitions, and innovative product launches. In order to consolidate their market share and expand their range of products, companies have been merging.
Furthermore, firms can adopt acquisition strategies so as to incorporate advanced technologies within their operations thereby improving research and development capabilities. Again, manufacturers have capitalized on these opportunities by introducing new products with significant health benefits.
Specifically, they have come up with novel excipients which are capable of improving the bioavailability and stability of various nutraceuticals and thus supporting personalized nutrition trends.
To maintain and improve growth, companies are adopting strategies such as expanding their geographic presence, forming strategic alliances, and investing in sustainable and clean-label ingredients. It is also important to focus on regulatory compliance issues considering that quality control is not only important for customer loyalty but also for the overall competitiveness of any company.
As per Product Type, the industry has been categorized into Binders, Fillers & Diluents, Disintegrants, Lubricants, Coating Agents, Flavoring Agents, Coloring Agents, and Others.
As per End Use, the industry has been categorized into Dry & Liquid.
As per End Use, the industry has been categorized into Protein & Amino Acids, Omega 3 Fatty Acids, Vitamins, Minerals, Prebiotics & Postbiotics, and Others.
Industry analysis has been carried out in key countries of North America, Latin America, Western Europe Eastern Europe, Balkans & Baltic, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and Middle East & Africa.
The global market is estimated at a value of USD 2,663.4 million in 2024.
Prominent players in the landscape include Ingredion Incorporated, Cargill Incorporated, Dow Du Pont Inc, Kerry Group PLC, Roquette Frères SA, Lubrizol Corporation, and Ashland Global Holdings Inc.
The Global Industry grew at a Historical CAGR of 5.1% from 2019 to 2023.
The USA market is projected to hold a revenue share of 28.0% over the forecast period.
The industry is projected to grow at a forecast CAGR of 6.4% from 2024 to 2034.
Explore Similar Insights
Nutraceutical Excipients Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
